USSTOCK.TODAY
Regular Market
Log in Sign up

BioMarin Pharma Exceeds $1 billion in Quarterly Revenue for the First Time

The Motley Fool +1 · ·by G4L

BMRN
BMRN Biomarin Pharmaceutical Inc
$57.18 +2.05%
View chart & analysis →
  1. 1BioMarin recorded its first-ever quarterly revenue exceeding $1 billion in the third quarter.
  2. 2BioMarin achieved a 32% year-over-year growth in third-quarter revenue.
  3. 3BioMarin recorded 44% revenue growth in its metabolic disease business in the third quarter.

So what's the key point?

BioMarin Pharma's third-quarter revenue surpassed $1 billion for the first time. The metabolic disease business drove this performance with 44% growth.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

Grifols beats expectations with 2.04 billion euro third-quarter revenue Nasdaq +1 · Nov 3BioMarin Q3 Earnings Release: A Test of the Gap Between Business Performance and Stock Price Earnings Whispers · Oct 27Sprout Social beats 2Q adjusted EPS estimate at 26 cents Associated Press +1 · Aug 7
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news